Rodman & Renshaw analyst Brandon Folkes initiated coverage of PolyPid (PYPD) with a Buy rating and $13 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- PolyPid files to sell 11.23M ordinary shares for holders
- PolyPid Regains Nasdaq Compliance with Private Placement Boost
- PolyPid Advances Phase 3 Trial and Secures Financing
- PolyPid price target lowered to $11 from $14 at H.C. Wainwright
- PolyPid announces DSMB recommendation to continue Phase 3 D-PLEX study
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue